Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 7/14/2014
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||H022294 / -||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Orthostatic hypotension
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Other Medications: No other medications
Current Illness: Immunisation
Diagnostic Lab Data:
CDC 'Split Type': WAES1403SWE011186
Write-up:Information has been received from Sanofi Pasteur MSD (SPM) (manufacturer control # E2014-02490) on 21-MAR-2014. Case was received from a health professional via the Health Authorities on 19-Mar-2014 under the reference MPA-2014-001995. Case is medically confirmed. Primary source was a physician. A female patient (gender, weight, height not reported) with no medical history reported received a dose of GARDASIL (batch/lot no. H022294, expiry date 30-JUN-2015) via not reported route and site of administration on an unspecified date. On an unspecified date, the patient developed orthostatic hypotension. At the time of reporting, the patient had not recovered.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166